| 8080567 |
EP2 receptor agonists |
Alexander W. Oxford, Robert Alexander Coleman, Kenneth Lyle Clark, David Edward Clark, Shirley Ann Brunton +7 more |
2011-12-20 |
| 7858644 |
EP4 receptor antagonists |
Alexander W. Oxford, Robert Alexander Coleman, Kenneth Lyle Clark, David Edward Clark, Neil Victor Harris +5 more |
2010-12-28 |
| 7803841 |
EP2 receptor agonists |
Alexander W. Oxford, Robert Alexander Coleman, Kenneth Lyle Clark, David Edward Clark, Neil Victor Harris +7 more |
2010-09-28 |
| 7662839 |
EP2 receptor agonists |
Alexander W. Oxford, Robert Alexander Coleman, Kenneth Lyle Clark, David Edward Clark, Neil Victor Harris +7 more |
2010-02-16 |
| 7569602 |
Furan derivatives as EP4 receptor antagonists |
David Edward Clark, Neil Victor Harris, Garry Fenton, George Hynd, Keith Alfred James Stuttle +4 more |
2009-08-04 |
| 7528157 |
EP4 receptor antagonists |
Alexander W. Oxford, Robert Alexander Coleman, Kenneth Lyle Clark, David Edward Clark, Neil Victor Harris +5 more |
2009-05-05 |
| 7507754 |
EP4 receptor antagonists |
Alexander W. Oxford, Robert Alexander Coleman, Kenneth Lyle Clark, David Edward Clark, Neil Victor Harris +5 more |
2009-03-24 |
| 7417068 |
EP4 receptor antagonists |
David Edward Clark, Neil Victor Harris, Garry Fenton, George Hynd, Keith Alfred James Stuttle +4 more |
2008-08-26 |
| 7326732 |
EP2 receptor agonists |
Alexander W. Oxford, Robert Alexander Coleman, Kenneth Lyle Clark, David Edward Clark, Neil Victor Harris +7 more |
2008-02-05 |
| 7196089 |
EP4 receptor antagonists |
Alexander W. Oxford, Robert Alexander Coleman, Kenneth Lyle Clark, David Edward Clark, Neil Victor Harris +5 more |
2007-03-27 |
| 6780839 |
Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
Keith Page |
2004-08-24 |